Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Breast Cancer - Research from B. Kaufman and colleagues provide new insights into breast cancer
Breast Cancer - Research from Vanderbilt University in the area of breast cancer published
Cancer - Research on cancer reported by scientists at Micromet AG
Colon Cancer - Recent findings in colon cancer described by E. Skof and colleagues
Colon Cancer - Study data from J.L. Raoul and co-authors update knowledge of colon cancer
Crohn Disease - Research from M. Takazoe et al has provided new information about Crohn disease
Heart Disease - Researchers from Duke University report recent findings in heart disease
Life Sciences - Research on life sciences reported by M.B. Jameson et al
Lung Disease - Researchers from Emory University report details of new studies and findings in the area of lung disease
Neutropenia - Reports on neutropenia findings from J.E. Rosenberg and co-researchers provide new insights
Non-Hodgkin Lymphoma - Study data from J.D. Hainsworth et al provide new insights into non-hodgkin lymphoma
Non-Small Cell Lung Cancer - Research on non-small cell lung cancer published by scientists at University of North Carolina
Osteoarthritis - New osteoarthritis research from Northwestern University discussed
Breast Cancer Therapy - Data on breast cancer therapy described by N. Tubiana-Mathieu et al
Large-Cell Lymphoma Therapy - Investigators at University of Alabama, Birmingham Comprehensive Cancer Center publish new data on large-cell lymphoma therapy
Myeloma Therapy - New findings from Mayo Clinic, Division of Hematology describe advances in myeloma therapy
Solid Cancer Therapy - New solid cancer therapy research has been reported by V. Gregorc et al
Anxiety Disorders - Study Showed VYVANSE® (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Array BioPharma Inc. - Array BioPharma Advances Its Lead MEK Inhibitor into Cancer
Breast Cancer - Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial
Cancer - Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Cancer Vaccines - ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens
Clinical Trial Research - Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio a Syndrome
Cutaneous T-Cell Lymphoma - Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clerazide for Treatment of Cutaneous T-Cell Lymphoma
Daiichi Sankyo, Inc. - Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
Elan Corporation - Elan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
Endocyte Inc. - Endocyte to Present Data on EC145 at the IASLC 13th World Conference on Lung Cancer
Genta Incorporated - New Publication Confirms Critical Link of LDH Biomarker in Genasense® Trials to Overall Survival in Advanced Melanoma
Halozyme Therapeutics, Inc. - Halozyme Begins Phase 2 Clinical Trial of Insulin-PH20 in Type 2 Diabetic Patients
Heart Failure - Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
Humanetics Corporation - Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics Corporation
Influenza - BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Medarex, Inc. - Medarex to Receive Milestone Payment from FibroGen for the Initiation of a Phase 2 Study of FG-3019 in Patients with Diabetic Kidney Disease
Mentor Capital, Inc. - Mentor Capital, Inc. Acquires 20% of Cutting Edge Cancer Immunotherapy Company: Quantum Immunologics, Inc.
Mentor Capital, Inc. - Quantum Immunologics, a Major Mentor Capital Investee, Starts FDA-Authorized Breast Cancer Trials
Noven Pharmaceuticals, Inc. - Noven Reports Positive Phase 2 Results for Mesafem™ Non-Hormonal Therapy for Vasomotor Symptoms
Pfizer Inc - Pfizer Announces New Phase 1 Data From Two Novel Compounds for Alzheimer's Disease At ICAD Annual Meeting
Schering-Plough Corporation - Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
Solid Cancer - Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
West Nile Virus - MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
